VTRS LAWSUIT: Lose Money on Viatris Inc.? Contact BFA Law before June 3 Court Deadline — Neutral
VTRS GlobeNewsWire — May 21, 2025NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Viatris, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/viatris-inc.

BBAI LAWSUIT: Lose Money on BigBear.ai Holdings, Inc.? Contact BFA Law before June 10 Court Deadline — Neutral
BBAI GlobeNewsWire — May 21, 2025NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BigBear.ai Holdings, Inc. (NYSE: BBAI) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in BigBear.ai, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/bigbearai-holdings-inc.

Stocks Snap Winning Streak, PANW and TGT Slide After Earnings — Negative
PANW SNAP TGT Schwab Network — May 21, 2025Equity futures are pointing to a second straight negative day after the SPX snapped its six-day winnings streak on Tuesday. Kevin Green sees markets entering a "wait-and-see" mode as investors may be taking profits from the recent rally and waiting commentary from Fed speakers and additional tariff news.

Silexion Therapeutics Completes Key Preclinical Studies Exploring SIL204's Potential Impact on Colorectal and Lung Cancer — Neutral
SLXN GlobeNewsWire — May 21, 2025Silexion's new groundbreaking study explores the potential impact of its next generation RNAI therapeutic candidate beyond pancreatic cancer aiming to address critical unmet needs in additional KRAS-driven tumor types with treatment markets estimated at over $30 Billion Dollars a year Silexion's new groundbreaking study explores the potential impact of its next generation RNAI therapeutic candidate beyond pancreatic cancer aiming to address critical unmet needs in additional KRAS-driven tumor types with treatment markets estimated at over $30 Billion Dollars a year

Under Armour: Positioned For A Turnaround

Cloudflare CEO on the rise of 'zero-click searches': It'll be much harder to be a content creator — Neutral
NET CNBC Television — May 21, 2025Cloudflare co-founder and CEO Matthew Prince joins 'Squawk Box' to discuss the rise of zero-click searches, how AI is disrupting the search economy, the future of content creators, and more.

IOVA LAWSUIT: Lose Money on Iovance Biotherapeutics, Inc.? Contact BFA Law before July 14 Court Deadline — Neutral
IOVA GlobeNewsWire — May 21, 2025NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/iovance-biotherapeutics-inc-class-action-lawsuit.

Petrobras Prepares Drill Ship Deployment for Oil Exploration in Amapa — Negative
PBR Zacks Investment Research — May 21, 2025PBR is set to deploy a drill ship to Amapa for oil exploration in the Foz do Amazonas Basin amid regulatory hurdles and environmental scrutiny.

Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) Beats Q1 Earnings and Revenue Estimates — Positive
YMM Zacks Investment Research — May 21, 2025Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.17 per share.

Target (TGT) Misses Q1 Earnings and Revenue Estimates — Negative
TGT Zacks Investment Research — May 21, 2025Target (TGT) came out with quarterly earnings of $1.30 per share, missing the Zacks Consensus Estimate of $1.62 per share. This compares to earnings of $2.03 per share a year ago.

Retail Earnings Continue; Target Disappoints While Lowe's Reaffirms Guidance — Negative
TGT Forbes — May 21, 2025Key Takeaways

Europe is moving forward with its approach to regulation and innovation, says Cisco CEO — Positive
CSCO CNBC International TV — May 21, 2025Chuck Robbins, the CEO of Cisco, discusses Cisco's business outlook and the global tech industry.

Gold price rallies on steady safe-haven demand — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — May 21, 2025Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update — Neutral
RSLS GlobeNewsWire — May 21, 2025IRVINE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported financial results for the first quarter ended March 31, 2025 and provided a corporate strategic update.

Transcat to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference — Neutral
TRNS Business Wire — May 21, 2025ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference.

Burger King targets families through movie partnerships in latest stage of turnaround — Positive
QSR CNBC — May 21, 2025Burger King is leaning into a "family-first" marketing strategy as it enters the next phase of its turnaround. Part of that strategy includes limited-time menu items inspired by the "live action" remake of "How to Train Your Dragon.

Tempus to Present at the William Blair 45th Annual Growth Stock Conference — Neutral
TEM Business Wire — May 21, 2025CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the William Blair 45th Annual Growth Stock Conference. The event will take place from June 3-5 in Chicago, IL. Jim Rogers, Chief Financial Officer of Tempus, will present on June 5. A live audio webcast of the presentation will be available here. About Tempus Tempus is a technology company advancing precision medicine throug.

Manhattan and Shopify Deliver Seamless Omnichannel Shopping Experiences with Latest Order Management Collaboration — Neutral
MANH Business Wire — May 21, 2025LAS VEGAS--(BUSINESS WIRE)--Today, Manhattan announced that a connector app to Manhattan Active® Order Management is now available in the Shopify App Store.

Argan, Inc. to Announce First Quarter Fiscal 2026 Results and Host Conference Call on Wednesday, June 4, 2025 — Neutral
AGX Business Wire — May 21, 2025ARLINGTON, Va.--(BUSINESS WIRE)--Argan, Inc. (NYSE: AGX) (“Argan” or the “Company”) today announced that the Company will release its first quarter 2026 financial results after the market closes on Wednesday, June 4, 2025. Management will host a webcast with an accompanying slide presentation and conference call on Wednesday, June 4, 2025 at 5:00 p.m. ET. Participants can access the live webcast by visiting this link. To access the call by phone, participants can use the following dial-in infor.
